Altre lingue Avecho Biotechnology Limited

Azioni

AVE

AU0000047441

Tempo differito Australian S.E. Altri mercati azionari 05:14:31 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,004 ^AUD	0,00%		0,00%	+14,29%

14/03	Avecho proseguirà con la sperimentazione di Fase III di un farmaco contro l'insonnia	MT
07/03	Avecho Biotechnology ottiene l'autorizzazione etica per la sperimentazione di fase tre sull'insonnia	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial	25/03
Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug	14/03
Avecho Biotechnology Secures Ethics Clearance for Phase Three Insomnia Trial	07/03
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Avecho Biotechnology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Avecho Biotechnology Achieves Two-Year Stability Milestone for CBD Capsule	22/06/23
US Patent Office Allows Avecho Biotechnology's Patent on 'Optimized' Manufacturing Method for Tocopheryl Phosphate Mixture	29/05/23
Avecho Biotechnology Signs Licensing Deal with Arthur Group for Development of Cancer Drugs	22/05/23
Avecho Biotechnology Begins Manufacturing for Oral Cannabidiol Capsules	17/05/23
Avecho Biotechnology Raises AU$2 Million Via Entitlement Offer; Shares Slip 20%	09/05/23
Avecho Biotechnology CEO optimistic about phase III insomnia CBD trial	04/04/23
Avecho Biotechnology Conducts Entitlement Offer to Raise $11 Million to Fund Pivotal Phase Iii Clinical Trial	03/04/23
Avecho Biotechnology Limited Auditor Raises 'Going Concern' Doubt	15/03/23
Avecho Biotechnology Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Avecho Biotechnology Expands Research Partnership for Cannabidiol Medication	22/02/23
Avecho Biotechnology Limited Announces Ongoing Collaboration with Lambert Initiative	21/02/23
Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA	12/01/23
Athenex Submits Avecho's Phytonadione to FDA Pre-IND	12/01/23
Avecho Biotechnology Secures Ethics Approval for Phase 3 Insomnia Trial	22/12/22
Avecho Biotechnology Limited Receives Ethics Approval for its Pivotal Phase III Clinical Trial Testing its Oral CBD Softgel Capsule for Insomnia	21/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Avecho Biotechnology Limited

Azioni

AVE

AU0000047441

Altre lingue

Filtri